Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 17507447.
- Also identified by PMC identifier 2077949.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate the relationship between ratings of depressive symptoms and in vivo cortical acetylcholinesterase (AChE) activity in subjects with Parkinson's disease (PD) and parkinsonian dementia (PDem). Subjects (with PD, n = 18, including subjects with PDem, n = 6, and normal controls, n = 10) underwent [11C]methyl-4-piperidinyl propionate AChE positron emission tomography imaging and clinical assessment including the Cornell Scale for Depression in Dementia (CSDD). Subjects with PD and PDem had higher scores on the CSDD compared with normal controls: 7.3 (5.4) and 2.8 (2.6), respectively (F = 6.9, p = 0.01). Pooled analysis demonstrated a significant inverse correlation between cortical AChE activity and CSDD scores: R = -0.5, p = 0.007. This correlation remained significant after controlling for Mini-Mental State Examination scores. Depressive symptomatology is associated with cortical cholinergic denervation in PD that tends to be more prominent when dementia is present.
Medical subject headings
- Acetylcholinesterase
- Cholinergic Agents
- Dementia
- Depressive Disorder
- Parkinson Disease